Plus   Neg

Transcept, SNBL Sign Global Licensing Deal For Advanced Acute Migraine Treatment

Transcept Pharmaceuticals, Inc. (TSPT) and Shin Nippon Biomedical Laboratories, Ltd, or SNBL, announced that the companies have entered into an exclusive worldwide licensing agreement for a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine or DHE as the active drug.

The companies said the agreement grants Transcept the global development and commercialization rights to the product candidate, designated TO-2070, which is expected to offer a new and potentially improved approach to the treatment of acute migraine.

Preclinical data suggest that TO-2070 may offer significant migraine treatment benefits beyond those provided by less convenient and more invasive DHE drug delivery methods, such as injection, liquid nasal sprays or pulmonary inhalation.

Based on terms of the agreement, Transcept has agreed to pay SNBL an upfront technology license fee of $1 million, development milestones totaling $6.5 million through New Drug Application approval and, following the launch of the product, commercialization milestones tied to the achievement of specified annual sales levels totaling up to $35 million.

Additionally, Transcept will pay tiered, low double-digit royalties on annual net sales. The parties anticipate entering into further agreements under which SNBL would supply Transcept with nasal powder delivery devices and would provide Transcept with certain preclinical and clinical services to support TO-2070 development.

TO-2070 is based on a novel nasal powder drug delivery technology created by SNBL that combines a muco-adhesive drug carrier with a proprietary nasal powder drug delivery device.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Boeing (BA) will consider changing the name of the 737 MAX following its global grounding on safety concerns after two fatal crashes involving the jets in Ethiopia and Indonesia. Chief Financial Officer Greg Smith revealed this in an interview to Bloomberg on the sidelines of the Paris Air Show. He... Workers at Volkswagen AG's only factory in the U.S. have voted against forming a factory-wide union, dealing yet another blow to efforts by the United Auto Workers union to organize plants owned by foreign automakers. According to preliminary results announced on Friday, 833 workers at Volkswagen's plant in Chattanooga, Tennessee, reportedly voted against union representation. International Business Machines Corp. and Cúram Software, acquired by the tech giant in 2011, have agreed to pay $14.8 million to settle alleged violations of the False Claims Act, the Justice Department said in a statement. According to the DOJ, IBM and Cúram allegedly made material misrepresentations to the State of Maryland during a contract award process in 2011 and 2012.
Follow RTT